6
Apr 2026
Tuberculosis rates for Inuit living in Nunavik, the Inuit lands in northern Quebec, are 1000 times greater than among non-foreign-born Quebeckers, and underresourcing of local health care adds to hardship from the disease, found new research published in CMAJ.
6
Apr 2026
Japan's transition to a super-aged society is intensifying pressure on healthcare and social security spending.
3
Apr 2026
New research from Michigan State University challenges the popular assumption that narcissists gradually damage their relationships over time.
3
Apr 2026
In new research to be presented at this year's European Congress on Obesity (ECO2026) in Istanbul, Turkey (12-15 May), researchers show an increased risk of stroke in young adulthood for children of low birthweight, independent of their body mass index (BMI) as young adults or gestational age at birth.
3
Apr 2026
People of color who are also part of sexual and gender minority groups face unique challenges shaped by overlapping forms of discrimination. While much research has focused on the mental health risks they experience, far less has explored how people of these multiple identities build strength and resilience.
3
Apr 2026
Myotonic dystrophy type 1 (DM1) is the most common cause of adult-onset muscular dystrophy, a genetic disorder that leads to muscle weakness and wasting, but also affects the brain, the gastrointestinal tract and the heart.
3
Apr 2026
Sexually transmitted infections (STIs) not only impact an individual's health but also result in multibillion-dollar economic losses worldwide.
3
Apr 2026
Biomedical researchers have designed an injectable microgel to help reduce bleeding in infants who require surgical care. In an animal model, the engineered microgel reduced bleeding by at least 50%.
3
Apr 2026
The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, is monitoring the SARS-CoV-2 variant BA.3.2, sometimes informally referred to in media reports as the "cicada" variant, and emphasizes that current evidence does not indicate cause for alarm or heightened public concern.
3
Apr 2026
A novel vaccine platform has been developed to induce broad, protective immunity against numerous influenza virus infections, showing promise as an effective mucosal vaccine strategy, according to a study published by researchers in the Institute for Biomedical Sciences at Georgia State University.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
